Plasma magnesium in patients submitted to cardiac surgery and its influence on perioperative morbidity

J Cardiovasc Surg (Torino). 2001 Feb;42(1):37-42.

Abstract

Background: To determine the changes in magnesaemia in cardiac surgical patients submitted to cardiopulmonary bypass (CPB) and their influence on perioperative morbidity.

Setting: the cardiovascular surgery department of a university hospital.

Patients: 60 patients of both sexes, mean age 60+/-12 yrs, operated on consecutively for myocardial revascularization or valve replacement.

Interventions: plasma Mg2+ levels were measured preoperatively, during CPB, postCPB and throughout the first 24 hrs after operation. Preoperative plasma Mg2+ levels of these patients were compared with those of 15 non-cardiac surgical patients and 11 healthy volunteers.

Results: Mean values of Mg2+ similar in the three populations although in the group of cardiac patients the number of hypomagnesaemic patients was significantly higher (16 patients=26.6%). In these 16 patients, preoperative hypomagnesaemia had a statistically significant relationship with the preoperative treatment with beta-blockers and previous history of arrhythmias (p<0.05). A progressive statistically significant decrease of Mg2+ was observed throughout the surgery that remained low at 24 hours postoperatively (p<0.05). Normomagnesemic patients needed significantly more shocks and electrical energy to obtain heart defibrillation after CPB. The incidence of both postoperative arrhythmias and postoperative low cardiac index (<2.5 L.m2) was statistically significantly more frequent in hypomagnesaemic patients (p<0.05).

Conclusions: Preoperative hypomagnesaemia was more frequent in this small sample of cardiac surgical patients than in non-cardiac surgical patients and was related to preoperative treatment with b-blockers. Hypomagne-saemia caused by CPB persisted 24 hrs after operation and was associated with higher incidence of both postoperative arrhythmias and low cardiac index.

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Adult
  • Arrhythmias, Cardiac / blood
  • Arrhythmias, Cardiac / etiology
  • Arrhythmias, Cardiac / therapy
  • Cardiac Output
  • Cardiac Surgical Procedures*
  • Cardiopulmonary Bypass*
  • Electric Countershock
  • Female
  • Humans
  • Intraoperative Complications / blood*
  • Intraoperative Complications / therapy
  • Magnesium / blood*
  • Male
  • Middle Aged
  • Postoperative Complications / blood*
  • Respiration, Artificial

Substances

  • Adrenergic beta-Antagonists
  • Magnesium